岩手県盛岡市みたけの眼科 むらた眼科クリニック

盛岡市みたけの眼科 むらた眼科クリニック

〒020-0122
岩手県盛岡市みたけ5-8-30
TEL 019-648-8571
▲Mobile Site 
トップページ»  Murata Eye Clinic product

Murata Eye Clinic product

Resources Implant Insertion System (ARVO, 2017)

Resources

Purpose.  To investigate the feasibility of retro-ocular implantation for an intrachoroidal sustained dexamethasone (DEX) delivery system as a potentially useful therapy for adjusting the most effective drug level to posterior segment eye diseases.
Methods.  A gelatin implant was prepared by incorporating DEX or fluorescein. A DEX or fluorescein implant was inserted into a rabbit vitreous, sclera, or choroid. The retina was extracted at 1, 3, or 24 hours, and the DEX level was measured by mass spectrometry. The fluorescein image was examined by ophthalmoscopy at 1 hour. An implant was also prepared by dissolving poly(DL-lactide)(PLA) and DEX. The DEX-PLA implant was inserted into a rabbit choroid using the retro-ocular implantation technique, and the retinal DEX level was measured at 24 hours, 1 week, and 3 weeks. The toxicity of the implant was evaluated by ophthalmoscopy and light microscopy. Endotoxin-induced uveitis (EIU) was induced after DEX-PLA implantation, and anti-inflammatory activities were evaluated by histopathological studies.

 

Resources Tube Insertion System (ARVO, 2017)​

Tube insertion has a long history of medical use, including ophthalmology. The intrachoroidal tube placement by using retro-ocular insertion through scleral approach would be useful to decrease tissue damages and increase the DEX level in posterior eye segment, especially disc-macula area locally. In addition, the intrachoroidal tube near the disc might be possible to maintain drug level by repeating drug injections through the tube.

This time, we have invented a simple procedure of a tube insertion through sclera for the intrachoroidal DEX delivery in posterior eye segment. This procedure would be helpful to increase DEX level in disc-macula area, and to maintain effective retino-choroidal DEX level by repeating the DEX injections. Therefore, in this study, we assessed whether this procedure was useful to maintain the DEX level in the posterior eye segment near the disc.
 

Resources
 
 

Resources Laser-induced intrachoroidal dexamethasone drug delivery  (IOVS, 2013)​

Purpose. To investigate the feasibility of laser-induced intrachoroidal dexamethasone (DEX) delivery as a potentially useful therapy for adjusting the most effective drug level to posterior segment eye diseases.

Methods. The implant was prepared by dissolving poly(DL-lactide) and DEX. In vitro release of DEX was evaluated at 7, 14, and 28 days by ELISA. In vivo, the DEX implant was inserted into the rabbit choroid, and then 10, 50, or 200 burns of photocoagulation were applied at the implant lesion, respectively. After treatment, the vitreous humor was immediately aspirated and the DEX level was measured by LC/MS/MS. Furthermore, the vitreous DEX level was measured at 1, 7, 14, and 28 days after the implantation and 50 burns of photocoagulation. The toxicity of laser-induced DEX implant was evaluated by ophthalmoscopy and light microscopy.

Endotoxin-induced uveitis (EIU) was induced after the DEX implantation and photocoagulation, and the anti-inflammatory activities were evaluated by grading clinical signs, protein concentrations, and histopathologic studies, respectively.
 

Resources
 
 

Resources Feasibility of biodegradable intra-choroidal implantation (2011,ARVO)​

Purpose: To understand the possible roles of intra-choroidal implantation, we investigated the in vivo release of betamethasone phosphate (BP) from the intra-choroidal implant. Furthermore, we sought to evaluate the effect of intra-choroidal implantation of basic fibroblast growth factor (bFGF)–impregnated gelatin in promoting choroidal neovascularization (CNV).

Methods: 1) The intra-choroidal implant was made of poly(DL-lactide) containing 50% BP(0.15mg). The implant prepared as above was inserted into a choroidal pocket in the rabbit’s eye. The concentration of BP in the choroid sample at 4 weeks after implantation was determined by high-performance liquid chromatography (HPLC).

2) The intra-choroidal implant was made of gelatin impregnated 1μg of bFGF. The implant was placed into a choroidal pocket in the rabbit’s eye. The treated eye was examined by fluorescein angiography and light microscopy at weeks 2.
 

Resources
 
 

ContactUs

Murata Eye Clinic
5-8-30 Mitake, Morioka city, JAPAN 020-0122
murata-ganka@cap.ocn.ne.jp

ContactUs